Stewart, C A <br/><br/>
Iron absorption in patients with Zollinger-Ellison syndrome treated with long-term gastric acid antisecretory therapy.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  Jan 1998 
 - 83-98 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0269-2813 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2036.1998.00274.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Anemia--chemically induced<br/>Antacids--administration & dosage<br/>Anti-Ulcer Agents--administration & dosage<br/>Clinical Protocols<br/>Female<br/>Gastric Acid--metabolism<br/>Histamine H2 Antagonists--administration & dosage<br/>Humans<br/>Intestinal Absorption--drug effects<br/>Iron--blood<br/>Iron Deficiencies<br/>Male<br/>Middle Aged<br/>National Institutes of Health (U.S.)<br/>Omeprazole--administration & dosage<br/>United States<br/>Zollinger-Ellison Syndrome--blood